Investor Relations

For press releases prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc. (known as Innoviva, Inc. since January 7, 2016), please visit Innoviva, Inc. Investor Relations Press Releases.


Press Releases
Date Title and Summary View
May 23, 2017 DUBLIN and HERTFORDSHIRE, United Kingdom and PITTSBURGH, May 23, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ, TASE: MYL) ("...
May 17, 2017 DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, May 17, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ, TASE: MYL) ("Mylan")...
May 9, 2017 DUBLIN, May 9, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported financial results for the first quarter ended March 31,...
May 2, 2017 DUBLIN, May 2, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the period ...
Apr 27, 2017 DUBLIN, April 27, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that members of management will present a corporate overview at the Deutsche Bank 42nd Annual...
Apr 25, 2017 DUBLIN, April 25, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced the presentation of positive new data from several ...
Apr 24, 2017 DUBLIN, April 24, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that new preliminary data from the ongoing Telavanc...
Apr 18, 2017 DUBLIN, April 18, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that data from new studies of VIBATIV® (telava...
Mar 28, 2017 DUBLIN, March 28, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that Rick E Winningham, Chairman and Chief Executive Officer, will present a corporate overvi...
Feb 27, 2017 DUBLIN, Feb. 27, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported financial results for the fourth quarter and full yea...
1
... NextLast
Add to Briefcase = add release to Briefcase
By clicking on the link below, you will leave www.theravance.com.
CancelContinue
Form content here please :)